Search for: "Downs v. Eli Lilly and Company" Results 1 - 20 of 119
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 May 2017, 11:36 am by Howard Knopf
Undaunted by the SCC’s leave refusal, which would absolutely have been the end of the litigation for any Canadian party, Eli Lilly and Company (“Eli Lilly”), an American “foreign investor” and the parent company of Canadian Eli Lilly  decided to launch a NAFTA challenge, which it commenced on September 12, 2013 under the ultra-controversial Investor State Dispute Settlement (“ISDS”)… [read post]
1 May 2017, 11:36 am by Howard Knopf
Undaunted by the SCC’s leave refusal, which would absolutely have been the end of the litigation for any Canadian party, Eli Lilly and Company (“Eli Lilly”), an American “foreign investor” and the parent company of Canadian Eli Lilly  decided to launch a NAFTA challenge, which it commenced on September 12, 2013 under the ultra-controversial Investor State Dispute Settlement (“ISDS”)… [read post]
27 Dec 2006, 4:14 pm
Here is a link to the United States Court of Appeals for the Federal Circuit 23-page opinion in the case of Eli Lilly v. [read post]
3 Dec 2014, 11:24 am by Robert Kreisman
A U.S. district court judge has rejected the attempts of Takeda Pharmaceutical Co. and Eli Lilly & Co. to overturn the combined $9 billion punitive-damage award that a jury recently returned. [read post]
19 Jul 2011, 1:35 am by Dr. Stuart Baran
  In Human Genome Sciences Inc v Eli Lilly and Company [2010] EWCA Civ 33, all of these questions had to be considered before evaluating the validity of a patent owned by Human Genome Sciences (“HGS”). [read post]
13 Oct 2008, 2:41 pm
Hot off the press comes the ruling today of Mr Justice Floyd (Patents Court, England and Wales) in Dr Reddy's Laboratories (UK) Ltd v Eli Lilly and Company Ltd [2008] EWHC 2345 (Pat). [read post]
27 Sep 2017, 3:29 am
  She is doing her best to digest this month's decision of Fresenius Kabi Oncology Plc and Ors v Eli Lilly & Company and Ors (N.R.G. 54470/2016) (available on darts-ip) by reference to an automated online translation of the decision, and so asks that readers bear with her. [read post]
2 Nov 2011, 12:57 pm
Still, you can’t blame the inventor for trying… The dispute in Human Genome Sciences v Eli Lilly is, by comparison, a whole other kettle of fish. [read post]
17 Jul 2011, 9:55 am by Hugh Tomlinson QC, Matrix Law
There are two appeals in the Supreme Court beginning with Human Genome Sciences Inc v Eli Lilly and Company to be heard on Monday 18 to Wednesday 20 July 2011 by Lords Hope, Walker, Neuberger, Collins and Clarke. [read post]
26 Jun 2015, 12:30 am
 In the admirably brief Court of Appeal decision just out - Actavis UK Ltd & Others v Eli Lilly & Company [2015] EWCA Civ 555 (25 June 2015) , Lord Justice Floyd (Lord Justice Kitchin and Lord Justice Longmore concurring) disagreed with Arnold J on two main issues - one on which nothing turns in the end (although it has important wider significance), and one which has the result that this case seems set to run and run.The claimBut let's recap a… [read post]
5 Jul 2015, 4:18 am by Mark Summerfield
  Furthermore, the previous week the England and Wales Court of Appeal issued a decision in Actavis UK Ltd & Ors v Eli Lilly & Company [2015] EWCA Civ 555, which also involved Swiss-type claims.It is interesting to compare the two decisions, particularly because, in my view, the UK court managed to completely undermine the European prohibition on patents for methods of medical treatment and must surely, therefore, be wrong! [read post]
2 Nov 2011, 11:56 pm by Dharmendra Chatur
Human Genome Sciences Inc (Appellant) v Eli Lilly and Company (Respondent) [see judgment, press summary, BAILII] In holding that gene sequences can have industrial application, reversing the lower courts’ findings, the Supreme Court gave primacy two policy arguments- attracting biosciences investment into the UK and bringing UK interpretations in compliance with the European Patent Convention. [read post]
15 Jul 2017, 5:11 am
The summary stated that the Supreme Court allows Eli Lilly's appeal and holds that Actavis' products directly infringe Eli Lilly's patent in the United Kingdom, France, Italy and Spain. [read post]
6 Sep 2013, 7:22 am by Dan Harris
The ruling came from Shanghai’s No. 1 Intermediate Court in the case of Eli Lilly v. [read post]
11 Sep 2017, 1:30 am by Jani Ihalainen
In an attempt to clarify the position, the UK Supreme Court took on a case that involves two rivals in the pharmaceutical business.The case of Eli Lilly v Actavis UK Ltd dealt with the chemical Pemetrexed, developed by Eli Lilly, used for the treatment of cancerous tumors. [read post]
31 Oct 2017, 12:05 am
Limited and others v Yeda Research and Development Company Limited and others [2017] EWHC 2629 (Pat) - the first application of Actavis v Eli Lilly in the Patents Court. [read post]